The first description of pheochromocytoma in 1886 has been attributed to Felix Fränkel, who described an 18-year-old woman with bilateral adrenal “sarcoma and angio-sarcoma.” We reviewed the ...

Pheochromocytoma and paraganglioma are related tumors that differ mainly in location; pheochromocytomas are adrenal, and paragangliomas can be anywhere else. The symptoms are protean and common, bu ...

This Case Report discusses the retinochoroidal features leading to diagnosis of malignant hypertension in a child with bilateral optic disc swelling. Blood pressure determination is crucial.

Signs and symptoms of pheochromocytoma can be highly varied, reflecting the hemodynamic and metabolic activities of the catecholamines that are produced and secreted by the tumors.

Second, because of widespread use of anatomic imaging studies, adrenal incidentalomas have become an important clinical entity for which pheochromocytoma must be considered, regardless of signs ...

The Food and Drug Administration approved belzutifan, or Welireg, marketed by Merck (MRK), for adult and pediatric patients 12 years and older with locally advanced, unresectable, or metastatic ...

Pheochromocytoma is a rare tumor of the adrenal glands that secretes the catecholamines, adrenaline and noradrenaline. Symptoms, diagnosis, treatment of adrenal gland tumor are explained in detail.

Pheochromocytoma and paraganglioma are rare tumors that come from the same tissue, but pheochromocytoma form in the adrenal gland and paraganglioma form outside the adrenal gland.

Pheochromocytoma, a rare condition caused by a tumor in the adrenal medulla affecting the chromaffin cells, results in an excess production of catecholamines (epinephrine and norepinephrine) and ...

Treatment for pheochromocytoma usually involves surgery to remove the mass and part of the adrenal gland (partial adrenalectomy) or surgery to remove the entire adrenal gland (adrenalectomy).

The FDA has approved Welireg (belzutifan) for adult and pediatric patients 12 years and older with locally advanced, unresectable, or metastatic PPGL.

Case studies have reported that ECMO can be used to successfully manage pheochromocytoma-induced TCM or cardiogenic shock, as shown in our patient. 10 This patient experienced an uncommon occurrence ...